Risk factor | Baseline (T0) | 3-Year follow-up (T3) | 4-Year follow-up (T4) | 5-Year follow-up (T5) |
---|---|---|---|---|
Serum total cholesterol (mg/dL) (N=6089) | ||||
Mean (SD) | 187.6 (37.9) | 197.6 (37.7) | 196.2 (38.2) | 207.3 (40.2) |
Mean (SE) Δ change from T0 | +10.0 (0.4) | +8.5 (0.4) | +19.7 (0.4) | |
95% CI for Δ change | (9.0 to 11.0)*** | (7.5 to 9.6)*** | (18.6 to 20.8)*** | |
Fasting plasma glucose (mg/dL) (N=6240) | ||||
Mean (SD) | 87.4 (20.3) | 90.7 (23.7) | 91.7 (24.4) | 94.4 (27.7) |
Mean (SE) Δ change from T0 | +3.4 (0.3) | +4.4 (0.3) | +7.1 (0.3) | |
95% CI for Δ change | (2.7 to 4.1)*** | (3.6 to 5.1)*** | (6.3 to 7.9)*** | |
Systolic blood pressure (mm Hg) (N=6684) | ||||
Mean (SD) | 114.1 (13.3) | 118.0 (14.6) | 121.1 (15.6) | 123.9 (16.3) |
Mean (SE) Δ change from T0 | +3.9 (0.2) | +7.0 (0.2) | +9.8 (0.2) | |
95% CI for Δ change | (3.3 to 4.4)*** | (6.4 to 7.5)*** | (9.2 to 10.3)*** | |
Diastolic blood pressure (mm Hg) (N=6380) | ||||
Mean (SD) | 75.0 (9.5) | 76.4 (10.6) | 79.3 (10.9) | 81.0 (11.2) |
Mean (SE) Δ change from T0 | +1.4 (0.1) | +4.3 (0.2) | +6.0 (0.2) | |
95% CI for Δ change | (1.0 to 1.8)*** | (3.9 to 4.7)*** | (5.6 to 6.4)*** | |
Body mass index (kg/m2) (N=6384) | ||||
Mean (SD) | 24.7 (3.7) | 25.1 (3.6) | 25.4 (3.7) | 25.8 (3.7) |
Mean (SE) Δ change from T0 | +0.4 (0.03) | +0.7 (0.03) | +1.1 (0.03) | |
95% CI for Δ change | (0.3 to 0.4)*** | (0.6 to 0.8)*** | (1.0 to 1.2)*** |
p Values are based on one-way repeated measures analysis of variance analyses.
*p<0.05, **p<0.01, ***p<0.001.